Johnson & Johnson
pharma New Brunswick, NJ · JNJ · Public
Johnson & Johnson maintains a streamlined portfolio focused on Innovative Medicine and MedTech following its 2023 divestiture of Consumer Health to Kenvue, positioning itself for higher-growth innovation. Recent market commentary highlights J&J as a defensive dividend stock attracting capital away from the technology sector amid market volatility concerns.
Johnson & Johnson (JNJ) operates globally, engaging in the research, development, production, and distribution of a diverse range of healthcare products. In a pivotal strategic move in 2023, the company divested its Consumer Health division, establishing it as the independent entity Kenvue Inc. This separation was implemented to allow J&J to sharpen its focus on higher-growth, innovation-led areas. Consequently, well-known consumer brands like TYLENOL, LISTERINE, and BAND-AID are now part of Kenvue's portfolio. Johnson & Johnson's current operations are centered around two primary divisions: Innovative Medicine and MedTech. The Innovative Medicine segment, formerly known as Pharmaceuticals, specializes in prescription drugs designed to treat complex ailments such as rheumatoid arthritis, various forms of cancer, HIV/AIDS, and neurodegenerative disorders. Its MedTech division, encompassing Medical Devices, delivers cutting-edge technological solutions, including electrophysiology equipment, neurovascular care products, orthopaedic implants for hips, knees, and spine, advanced surgical technologies, and ACUVUE brand disposable contact lenses. These two streamlined segments primarily cater to a client base comprising hospitals, medical professionals, wholesale distributors, and retail outlets. From its headquarters in New Brunswick, New Jersey, Johnson & Johnson continues to uphold its enduring mission of advancing human health, a commitment it has maintained since its founding in 1886.
Employees
138,100
Mfg Plants
20
All Facilities
26
Activity
3/10
Type
Public
Plant Locations (26 mapped)
JNJ Stock Price
Recent News
The $1 Million Retirement Mistake: Counting Income You’ll Never Get to Spend
247 Wallst · 6/19/2026
The Retirement Portfolio That Forks Over a $10,000 Check Every Month
247 Wallst · 6/19/2026
Smart Money Is Fleeing Tech for Johnson & Johnson Ahead of the Next Market Storm
The Motley Fool · 6/19/2026
Johnson & Johnson (JNJ) Could Be a Great Choice
Zacks Investment Research · 6/19/2026
J&J Stock Down 3% in 3 Months: Is the Dip a Buying Opportunity?
Zacks Investment Research · 6/19/2026
Johnson & Johnson (JNJ) Stock Slides as Market Rises: Facts to Know Before You Trade
Zacks Investment Research · 6/18/2026
The $1.5 Million Portfolio That Out-Earns the Median U.S. Household
247 Wallst · 6/18/2026
The Dividend Growth Path That Turns $60,000 a Year Into $125,000
247 Wallst · 6/17/2026
Manufacturing Plants (20)
Johnson & Johnson Surgical Vision – Irvine Campus
Irvine, CA
J&J Surgical Vision global HQ; manufactures TECNIS intraocular lens (IOL) insertion systems; R&D for cataract surgery devices; 1,600+ employees; acquired via Abbott Medical Optics 2017
Johnson & Johnson Vision Care – Jacksonville Campus
Jacksonville, FL
Manufactures >1.7 billion ACUVUE brand contact lenses annually; ~90% of US supply; $1B+ expansion announced June 2026 to add new distribution facility in NW Jacksonville; R&D also on site
Ethicon – Cornelia Manufacturing Plant
Cornelia, GA
Founded 1946; produces majority of world's supply of surgical sutures; supplies raw suture materials to other Ethicon plants; 500–999 employees; active as of 2024
DePuy Synthes – Warsaw Campus
Warsaw, IN
Original DePuy manufacturing site founded 1895; manufactures joint reconstruction implants (hip, knee), orthopaedic instruments; ~1,100 employees
DePuy Synthes – Raynham Campus
Raynham, MA
DePuy Synthes Spine manufacturing, R&D, and US commercial operations; spine implants and instruments including thoracolumbar, cervical, and minimally invasive systems; also DePuy Mitek sports medicine
Johnson & Johnson – Holly Springs NC Biologics Facility at FUJIFILM Diosynth Campus
Holly Springs, NC
$2B, 10-year commitment for dedicated 160,000 sq ft suite at FUJIFILM Diosynth Biotechnologies' biopharmaceutical campus; operational fall 2025; ~120 new jobs; biologic medicines production
Johnson & Johnson – Wilson NC Biologics Manufacturing Facility (under construction)
Wilson, NC
$2B investment; 500,000 sq ft biologics manufacturing for oncology, immunology, neuroscience, and cardiopulmonary medicines; groundbreaking March 2025; operational target 2028; 500+ permanent jobs
Johnson & Johnson – Wilson NC Drug Product Manufacturing Facility (2nd site, under construction)
Wilson, NC
Second multibillion-dollar facility in Wilson County announced Jan 2026; state-of-the-art drug product manufacturing for oncology and neurological diseases; ~500 additional jobs
Janssen Pharmaceuticals / J&J Innovative Medicine – Raritan Campus
Raritan, NJ
Primary US pharmaceutical manufacturing and supply-chain operations for Janssen; oral solid dosage and API production; part of the largest J&J NJ footprint
Ethicon Endo-Surgery – Cincinnati/Blue Ash Campus
Cincinnati, OH
Ethicon Endo-Surgery global HQ and manufacturing/R&D; makes HARMONIC ultrasonic energy devices, ENSEAL advanced bipolar energy, and minimally invasive surgical tools; ~1,400 employees
Janssen Biotech – Horsham Campus
Horsham, PA
Biologics manufacturing for Remicade (infliximab), Stelara (ustekinumab), Simponi, Doxil, Zytiga; 1,000–4,999 employees; key US biotech production site for Janssen
Johnson & Johnson – Lower Gwynedd Cell Therapy Facility (under construction)
Lower Gwynedd, PA
$1B+ next-generation cell therapy manufacturing facility announced Feb 2026; 154-acre parcel; operated by Janssen Biotech; 500 biomanufacturing jobs; expected operational 2031
Janssen Biotech – Malvern Campus
Malvern, PA
Biologics manufacturing site; monoclonal antibody and API production; founded as Centocor Biotech in early 1980s; now Janssen Biotech Inc.
DePuy Synthes – West Chester Campus
West Chester, PA
DePuy Synthes (formerly Synthes Inc.) US operations hub; manufacturing and R&D for trauma, spine (craniomaxillofacial), and surgical instruments; acquired by J&J in 2012
Johnson & Johnson / Ethicon Endo Surgery – Guaynabo Facility
Guaynabo, PR
Ethicon Endo Surgery LLC manufacturing and J&J International offices; produces surgical instruments, optical and medical devices; also serves as sales/marketing hub for Puerto Rico operations
Janssen Ortho LLC – Gurabo Pharmaceutical Manufacturing
Gurabo, PR
Founded 1981; two plants on same campus (Janssen Ortho + Janssen-Cilag Manufacturing); oral solid dosage manufacturing and API production; makes Xarelto, Prezista, Nucynta ER; one of two global launch sites for OSD; continuous manufacturing approved by FDA
Janssen Ortho – Manatí Plant (converted to Ethicon MedTech)
Manatí, PR
$168M investment 2024; refurbished former Janssen pharmaceutical facility converted to Ethicon MedTech production; produces sutures, hemostats, and wound closure devices; ~300 new jobs created; 100,000 sq ft expansion
Ethicon LLC – San Lorenzo Manufacturing Plant
San Lorenzo, PR
Primary Ethicon MedTech manufacturing hub in Puerto Rico; ~1,500 employees; produces surgery, orthopedic, and vision products; sutures, mesh, and medical devices; key supply base for J&J MedTech
Ethicon Endo-Surgery – El Paso Manufacturing Plant
El Paso, TX
Ethicon Endo-Mech and Energy (EM&E) manufacturing plant; produces endoscopic mechanical and energy surgical devices; zip code 79910; active as of 2025-2026
Ethicon – San Angelo Manufacturing Plant
San Angelo, TX
Opened 1964; produces ~80% of world's surgical sutures; also makes hemostats and Dermabond; 300,000 sq ft; celebrated 60th anniversary August 2024
Other Facilities (6)
Johnson & Johnson World Headquarters
New Brunswick, NJ · hq
Global corporate headquarters; 16-story tower opened 1983 on a 12-acre downtown campus
Ethicon Inc. – Somerville/Route 22 Headquarters
Somerville, NJ · hq
Corporate headquarters of Ethicon (J&J MedTech surgical subsidiary); administrative/commercial functions
Janssen Pharmaceuticals / J&J Innovative Medicine – Titusville Campus
Titusville, NJ · hq
US commercial HQ for J&J Innovative Medicine (formerly Janssen); ~1,500 employees on 242-acre campus; includes commercial, regulatory, and limited manufacturing functions including CAR-T operations; largest solar array in NJ
Janssen Research & Development – San Diego Campus
San Diego, CA · r&d
Janssen R&D West Coast hub (La Jolla/Torrey Pines area); drug discovery and development; includes JLABS @ San Diego incubator (40,000 sq ft); oncology and immunology research
Johnson & Johnson Innovation – San Francisco Bay Area (California Innovation Center)
South San Francisco, CA · r&d
JLABS @ South San Francisco; 30,000 sq ft innovation incubator and R&D hub; California Innovation Center opened 2013; note: Brisbane R&D campus (1600 Sierra Point Pkwy) was subleased to Nurix in 2025
Janssen Research & Development – Spring House Campus
Spring House, PA · r&d
Major Janssen pharmaceutical R&D campus, ~170 acres; drug discovery and development across oncology, immunology, neuroscience; formerly J&J Pharmaceutical Research & Development